InvestorsHub Logo
Post# of 253170
Next 10
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 200913

Thursday, 04/28/2016 5:21:31 PM

Thursday, April 28, 2016 5:21:31 PM

Post# of 253170
Re: HCV in China

According to GILD’s 1Q16 CC, there are 10-20M HCV patients in China who can afford treatment at "Western" prices; however, genotyping is uncommon, so there’s a need for pan-genotypic regimens.

Please see #msg-122114457 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.